[Clinical significance of factors of the alternative pathway].
Takemura
S
S
First Department of Internal Medicine, Kyoto Prefectural University of Medicine.
Kondo
M
M
D003167:Complement Activation; D003176:Complement C3 / Q000032:analysis; D003180:Complement C3b Inactivator Proteins / Q000032:analysis; D011415:Complement Factor B / Q000032:analysis; D017242:Complement Factor H; D015941:Complement Hemolytic Activity Assay; D003170:Complement Pathway, Alternative; D005921:Glomerulonephritis / Q000276:immunology; D015433:Glomerulonephritis, Membranous / Q000276:immunology; D006801:Humans; D005779:Immunodiffusion
C493495:CFH protein, human; D003176:Complement C3; D003180:Complement C3b Inactivator Proteins; D017242:Complement Factor H; D011415:Complement Factor B